Digest Network Come funziona
Network
/
Società
Zu
Non verificato

Zura Bio Limited

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteScienza

33 comunicati stampa

Guarda tutti i comunicati
29/06/2026
Salute
Igiene alimentare
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Industria
Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program
Fonte
Zura Bio Limited
Emittente
Business Wire
1.00
0
14/05/2026
Mercato azionario
Finanza
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Medicina - Varie
Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Fonte
Zura Bio Limited
Emittente
Business Wire
1.00
0
13/05/2026
Mercato del lavoro
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Medicina - Varie
Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer
Fonte
Zura Bio Limited
Emittente
Business Wire
1.00
0
07/05/2026
Mercato azionario
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Medicina - Varie
Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates
Fonte
Zura Bio Limited
Emittente
Business Wire
1.00
0
04/05/2026
Finanza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Zura Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Fonte
Zura Bio Limited
Emittente
Business Wire
1.00
0
19/03/2026
Mercato azionario
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Medicina - Varie
Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates
Fonte
Zura Bio Limited
Emittente
Business Wire
1.00
0
05/03/2026
Eventi
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress
Fonte
Zura Bio Limited
Emittente
Business Wire
1.00
0
02/03/2026
Eventi
Web e Social Network
Scienza
Biotecnologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
Zura Bio to Participate in Upcoming Investor Conferences
Fonte
Zura Bio Limited
Emittente
Business Wire
1.00
0
27/02/2026
Finanza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Fonte
Zura Bio Limited
Emittente
Business Wire
1.00
0
25/02/2026
Finanza
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
Fonte
Zura Bio Limited
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0